GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Collegium Pharmaceutical Inc (STU:354) » Definitions » Equity-to-Asset

Collegium Pharmaceutical (STU:354) Equity-to-Asset : 0.20 (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Collegium Pharmaceutical Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Collegium Pharmaceutical's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €204.4 Mil. Collegium Pharmaceutical's Total Assets for the quarter that ended in Mar. 2024 was €1,025.1 Mil. Therefore, Collegium Pharmaceutical's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.20.

The historical rank and industry rank for Collegium Pharmaceutical's Equity-to-Asset or its related term are showing as below:

STU:354' s Equity-to-Asset Range Over the Past 10 Years
Min: -2.41   Med: 0.29   Max: 0.9
Current: 0.2

During the past 11 years, the highest Equity to Asset Ratio of Collegium Pharmaceutical was 0.90. The lowest was -2.41. And the median was 0.29.

STU:354's Equity-to-Asset is ranked worse than
83.43% of 1086 companies
in the Drug Manufacturers industry
Industry Median: 0.58 vs STU:354: 0.20

Collegium Pharmaceutical Equity-to-Asset Historical Data

The historical data trend for Collegium Pharmaceutical's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Collegium Pharmaceutical Equity-to-Asset Chart

Collegium Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.29 0.29 0.29 0.17 0.17

Collegium Pharmaceutical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.17 0.15 0.17 0.20

Competitive Comparison of Collegium Pharmaceutical's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Collegium Pharmaceutical's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Collegium Pharmaceutical's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Collegium Pharmaceutical's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Collegium Pharmaceutical's Equity-to-Asset falls into.



Collegium Pharmaceutical Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Collegium Pharmaceutical's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=179.21/1048.413
=0.17

Collegium Pharmaceutical's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=204.395/1025.11
=0.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Collegium Pharmaceutical  (STU:354) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Collegium Pharmaceutical Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Collegium Pharmaceutical's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Collegium Pharmaceutical (STU:354) Business Description

Traded in Other Exchanges
Address
100 Technology Center Drive, Stoughton, MA, USA, 02072
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release & immediate-release formulations of tapentadol.

Collegium Pharmaceutical (STU:354) Headlines

No Headlines